MBOT

Microbot Medical Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 4/10
  • Value↑ 6/10
Microbot Medical sales and earnings growth
MBOT Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 43.75%
  • FCF Y/Y↓ -22.84%
Microbot Medical gross and profit margin trends
MBOT Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -257.76%
Microbot Medical net debt vs free cash flow
MBOT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Microbot Medical stock volatility is higher than the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗